Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,022 public trials 2,030 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Panobinostat and Carfilzomib in Treating Participants With Relapsed or Refractory Multiple Myeloma

NCT01301807

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery

NCT02767388

Conditions: Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +42 more
Locations: University of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details

Completed

LSA4 Protocol for the Treatment of Advanced Pediatric and Adolescent Non-Hodgkins Lymphoma

NCT00610883

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

A Safety and Effectiveness Study of Vaccine Therapy in Patients With Indolent Lymphoma

NCT00081809

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +27 more
Locations: M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma

NCT00574496

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +10 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

VELCADE®-BEAM and Autologous Hematopoietic Stem Cell Transplantation for Non-Hodgkin's Lymphoma, or Mantle Cell Lymphoma

NCT00571493

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: University of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details

Completed

A Combination of Acalabrutinib With R-CHOP for Patient Diffuse Large B-cell Lymphoma (DLBCL)

NCT03571308

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Southampton University Hospitals NHS Tust Southampton, Hampshire, United Kingdom

St James's University Hospital Leeds, United Kingdom

University College London Hospitals London, United Kingdom

The Christie NHS Foundation Trust Manchester, United Kingdom

View Trial Details

Completed

Prospective Study of the Prognostic Value of New Markers in Adults With ALK-positive Large Anaplastic Lymphoma

NCT03603847

Conditions: Anaplastic Large Cell Lymphoma, ALK-Positive, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: CHU Amiens - Hôpital Sud Amiens, France

CHU d'Estaing Clermont-Ferrand, France

APHP - Hopital Henri Mondor Créteil, France

CHU Grenoble Grenoble, France

View all 15 locations

View Trial Details

Completed

Dasatinib in Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00550615

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: University of Nebraska Medical Center, Internal Medicine Section of Oncology/Hematology Omaha, Nebraska, United States

View Trial Details

Completed

Pilot Test of Parent-Focused Cannabis-Related Actions and Practices Intervention for Adolescent Marijuana Abuse

NCT04923230

Conditions: Cannabis Use Disorder, Mild, Cannabis Use Disorder, Moderate, Chemically-Induced Disorders, +13 more
Locations: Center for Family and Adolescent Research Albuquerque, New Mexico, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions